Leptospirosis classification

Jump to navigation Jump to search

Leptospirosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Leptospirosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Primary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Leptospirosis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Leptospirosis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Leptospirosis classification

CDC on Leptospirosis classification

Leptospirosis classification in the news

Blogs on Leptospirosis classification

Directions to Hospitals Treating Leptospirosis

Risk calculators and risk factors for Leptospirosis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [2]

Overview

Classification

Acute Phase

  • Also known as Septicemic phase or leptospiremic phase.
  • Begins abruptly
  • Bacteria are present in the blood and CSF of the patient
  • Characterized by wide spectrum of nonspecific signs and symptoms such as fever, chills, headache and conjunctival suffusion making it very difficult to diagnose.[1]
  • Associate with severe myalgia
  • Other less common findings include: Photophobia, lymphadenopathy, abdominal pain, nausea, vomiting, a transient rash, sore throat, coughing or chest pain
  • Characterestic of this phase also includes: Mild form of leptospirosis in ~90% cases which lasts several days to a week, followed by a brief remission, during which the temperature drops and the symptoms disappear

Immune phase

  • It is also known as leptospiruric phase.
  • Circulating (IgM) antibodies are produced and leptospires are present in the urine
  • Characterestic findings that differentiate from other febrile illnesses are myalgia and conjunctival suffusion.[2]
  • Myalgia often involves in calf muscles, less commonly involves abdominal and para-spinal muscles.

Anicteric leptospirosis

  • More common but serious illness is uncommon
  • Most of cases present either subclinical or of very mild severity
  • Few cases present with a febrile illness of sudden onset
  • Other symptoms include chills, headache (severe with retro-orbital pain and photophobia), myalgia, abdominal pain, conjunctival suffusion, and skin rash (transient and last <24 hours)
  • May progress to aseptic meningitis in ≤25% of patients and more common in younger age group than the patients with icteric leptospirosis
  • Mortality is very less when compared to icteric leptospirosis

Icteric leptospirosis

  • Rapidly progressive and severe form of leptospirosis(Weil's disease)
  • In the severe form of leptospirosis renal failure, hepatic failure and pulmonary haemorrhage can occur and associate with Icterohaemorrhagiae.[3]
  • Less common form of leptospirosis with incidence of 5%-10%
  • Jaundice is not associate with hepatocellular injury, eventually LFT returns to normal after recovery
  • High mortality rate with a range of 5%-15%

References

  1. Bal AM (2005). "Unusual clinical manifestations of leptospirosis". J Postgrad Med. 51 (3): 179–83. PMID 16333189.
  2. Forbes AE, Zochowski WJ, Dubrey SW, Sivaprakasam V (2012). "Leptospirosis and Weil's disease in the UK". QJM. 105 (12): 1151–62. doi:10.1093/qjmed/hcs145. PMID 22843698.
  3. Katz AR, Ansdell VE, Effler PV, Middleton CR, Sasaki DM (2001). "Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974-1998". Clin Infect Dis. 33 (11): 1834–41. doi:10.1086/324084. PMID 11692294.